These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25823778)

  • 1. Potential use of auxiliary labels to promote patient awareness of pharmacogenetic testing.
    Haga SB; Moaddeb J
    Pharmacogenomics; 2015; 16(4):299-301. PubMed ID: 25823778
    [No Abstract]   [Full Text] [Related]  

  • 2. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of auxiliary prescription labels on the elderly ambulatory patient's drug knowledge.
    Gryfe-Becker BM; Segal HJ; Einarson TR
    DICP; 1989 Apr; 23(4):324-9. PubMed ID: 2728515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding pharmacogenetics information to drug labels: lessons learned.
    Haga SB; Thummel KE; Burke W
    Pharmacogenet Genomics; 2006 Dec; 16(12):847-54. PubMed ID: 17108808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of auxiliary labels to improve patient compliance.
    Fedder DO; Goldstein M; Manes T; Benko JE; Shangraw R
    Contemp Pharm Pract; 1979; 2(2):51-5. PubMed ID: 10241637
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationalizing the use of auxiliary label for oral oncology drugs.
    Ng T; Badry N; de Lemos ML
    J Oncol Pharm Pract; 2017 Jul; 23(5):338-343. PubMed ID: 27208015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics in critical care: atrial fibrillation as an exemplar.
    Prows CA; Beery TA
    Crit Care Nurs Clin North Am; 2008 Jun; 20(2):223-31, vi-vii. PubMed ID: 18424351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic information for patients on drug labels.
    Haga SB; Mills R; Moaddeb J
    Pharmgenomics Pers Med; 2014; 7():297-305. PubMed ID: 25342916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
    Roederer MW; Van Riper M; Valgus J; Knafl G; McLeod H
    Per Med; 2012 Jan; 9(1):19-27. PubMed ID: 29783293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
    Wang B; Canestaro WJ; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects of auxiliary labels on patient knowledge of precautionary drug information.
    Brown CS; Solovitz BL; Bryant SG; Guernsey BG; Fisher S
    Drug Intell Clin Pharm; 1988 Jun; 22(6):470-4. PubMed ID: 3396459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
    de Leon J; Spina E
    Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A call for accurate pharmacogenetic labeling: telling it like it is.
    Burke W; Thummel K
    JAMA Intern Med; 2014 Dec; 174(12):1945-6. PubMed ID: 25317574
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality?
    Vladutiu GD
    Mol Genet Metab; 2008 Jan; 93(1):1-4. PubMed ID: 18054511
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenomic biomarkers in drug labels: what do they tell us?
    Tutton R
    Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation of pharmacogenetic knowledge into cancer therapeutics.
    Yong WP; Innocenti F
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving prescription auxiliary labels to increase patient understanding.
    Locke MR; Shiyanbola OO; Gripentrog E
    J Am Pharm Assoc (2003); 2014; 54(3):267-74. PubMed ID: 24816353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providing patients with information on pharmacogenetic testing.
    Fleeman N; Dickson R
    Nurs Stand; 2009 Jan 28-Feb 3; 23(21):46-8. PubMed ID: 19248450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA perspectives on pharmacogenetic testing.
    Harper CC; Philip R; Robinowitz M; Gutman SI
    Expert Rev Mol Diagn; 2005 Sep; 5(5):643-8. PubMed ID: 16149867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.